Articles
Volume 5 Supplement 1
24th Congress of the International Association for Breast Cancer Research. Advances in human breast cancer research: preclinical models
- Meeting abstracts
- from 24th Congress of the International Association for Breast Cancer Research. Advances in human breast cancer research: preclinical models
- Sacramento, USA
- 1-5 November 2003
|
Oral presentation
Mouse models of human breast cancer: evolution or convolution? JE Green Breast Cancer Res 2003, 5(Suppl 1):1 (31 October 2003) |
|
Oral presentation
S-CJ Lin, K-F Lee, AY Nikitin, KM Bushnell, SG Hilsenbeck, RD Cardiff, A Li, K-W Kang, SA Frank, W-H Lee, EY-HP Lee Breast Cancer Res 2003, 5(Suppl 1):2 (31 October 2003) |
|
Oral presentation
Mouse models for BRCA1-associated breast cancer R-H Wang, W Li, X Xu, C Deng Breast Cancer Res 2003, 5(Suppl 1):3 (31 October 2003) |
|
Oral presentation
Integrin-mediated signal transduction in transgenic mouse models of human breast cancer DE White, S Blaess, U Mueller, S Dedhar, RD Cardiff, R St Arnaud, WJ Muller Breast Cancer Res 2003, 5(Suppl 1):4 (31 October 2003) |
|
Oral presentation
Reversibility and progression in conditional transgenic mouse models of breast cancer LA Chodosh, RB Boxer, SE Moody, BA Keister, CJ Sarkisian, JW Jang, GK Belka, CM Blakely, CP Portocarero, CJ Sterner, KL Notarfrancesco, EA Kauh Breast Cancer Res 2003, 5(Suppl 1):5 (31 October 2003) |
|
Oral presentation
Genetic manipulation of the mammary gland by transplantation P Edwards Breast Cancer Res 2003, 5(Suppl 1):6 (31 October 2003) |
|
Oral presentation
The Mutant Mouse Regional Resource Center Program KCK Lloyd Breast Cancer Res 2003, 5(Suppl 1):7 (31 October 2003) |
|
Oral presentation
SW Barthold Breast Cancer Res 2003, 5(Suppl 1):8 (31 October 2003) |
|
Oral presentation
Advanced immunophenotyping: more is better! N Baumgarth Breast Cancer Res 2003, 5(Suppl 1):9 (31 October 2003) |
|
Oral presentation
Whole Slide Imaging and telepathology J Galvez Breast Cancer Res 2003, 5(Suppl 1):10 (31 October 2003) |
|
Oral presentation
Mammary pathology of the genetically engineered mouse AD Borowsky Breast Cancer Res 2003, 5(Suppl 1):11 (31 October 2003) |
|
Oral presentation
Positron emission tomography and X-ray computed tomography: tools for mouse phenotyping? SR Cherry Breast Cancer Res 2003, 5(Suppl 1):12 (31 October 2003) |
|
Oral presentation
W Yang, C Kowal, E Sorensen, P Lassota Breast Cancer Res 2003, 5(Suppl 1):13 (31 October 2003) |
|
Oral presentation
Herceptin-sensitivity of HER2-transgenic mouse mammary tumors RH Schwall, P Hollingshead, S Erickson, J Winer, M Williams, D Dugger Breast Cancer Res 2003, 5(Suppl 1):14 (31 October 2003) |
|
Oral presentation
Role of animal models in oncology drug discovery R Kumar Breast Cancer Res 2003, 5(Suppl 1):15 (31 October 2003) |
|
Oral presentation
LM Wakefield, Y Yang, O Dukhanina, B Tang, M Mamura, JL Letterio, J Green, GT Merlino, MR Anver Breast Cancer Res 2003, 5(Suppl 1):16 (31 October 2003) |
|
Oral presentation
Development of a transgenic mouse line for the evaluation of the androgen receptor activity R Attar, C Cullinan, C-P Ho, M Swerdel, J Dell, RB Rowley, DJ Bol, J Ostrowski, K Mookhtiar, M Gottardis, R Weinmann Breast Cancer Res 2003, 5(Suppl 1):17 (31 October 2003) |
|
Oral presentation
Clinical breast cancer and estrogen HK Chew Breast Cancer Res 2003, 5(Suppl 1):18 (31 October 2003) |
|
Oral presentation
Pregnancy levels of estrogen prevents breast cancer S Nandi, RC Guzman, G Thordarson, L Rajkumar Breast Cancer Res 2003, 5(Suppl 1):19 (31 October 2003) |
|
Oral presentation
Steroid regulation of breast cancer cell proliferation RL Sutherland Breast Cancer Res 2003, 5(Suppl 1):20 (31 October 2003) |
